TLR2 and autoimmune disease: Caution is needed when selecting appropriate TLR2 adjuvants for Treg induction, because some ligands for TLR2/TLR1 signaling such as Pam3Cys have been shown to skew Treg toward a Th17 phenotype and might therefore increase the risk of developing autoimmune disease (38).